BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Merz AMA, Merz M, Hillengass J, Holstein SA, Mccarthy P. The evolving role of maintenance therapy following autologous stem cell transplantation in multiple myeloma. Expert Review of Anticancer Therapy 2019;19:889-98. [DOI: 10.1080/14737140.2019.1674142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Lv M, Liu Q. JMJD2C triggers the growth of multiple myeloma cells via activation of β‑catenin. Oncol Rep 2021;45:1162-70. [PMID: 33469678 DOI: 10.3892/or.2021.7934] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Villa NY, Rahman MM, Mamola J, D'Isabella J, Goras E, Kilbourne J, Lowe K, Daggett-Vondras J, Torres L, Christie J, Appel N, Cox AL, Kim JB, McFadden G. Autologous Transplantation Using Donor Leukocytes Loaded Ex Vivo with Oncolytic Myxoma Virus Can Eliminate Residual Multiple Myeloma. Mol Ther Oncolytics 2020;18:171-88. [PMID: 32695875 DOI: 10.1016/j.omto.2020.06.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Germans SK, Kulak O, Koduru P, Oliver D, Gagan J, Patel P, Anderson LD Jr, Fuda FS, Chen W, Jaso JM. Lenalidomide-Associated Secondary B-Lymphoblastic Leukemia/Lymphoma-A Unique Entity. Am J Clin Pathol 2020;154:816-27. [PMID: 32880627 DOI: 10.1093/ajcp/aqaa109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]